The expression and localization of neuregulin-1 (NrG1) in the gastrointestinal system of the rhesus monkey

Folia Histochemica et Cytobiologica

Volumn 51, Issue 1, 2013, Pages 38-44

  Zhao, Wei Jiang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

ErbB2; ErbB4; GI tract; Neuregulin 1 (NrG1); Rhesus monkey; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COLON; CONTROLLED STUDY; ESOPHAGUS; GASTROINTESTINAL TRACT; IMMUNOFLUORESCENCE; MORPHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHESUS MONKEY; SMALL INTESTINE; STOMACH; TISSUE DISTRIBUTION; TISSUE MICROARRAY;

MACACA MULATTA; MAMMALIA; PRIMATES;

EID: 84877038661     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2013.006     Document Type: Article

References (36)

1. Ritch PS, Carroll SL, Sontheimer H. Neuregulin-1 enhances survival of human astrocytic glioma cells. Glia. 2005;51:217-228
2. Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008;9:437-452
3. Bernstein HG, Lendeckel U, Bertram I et al. Localization of neuregulin-1alpha (heregulin-alpha) and one of its receptors, ErbB4 tyrosine kinase, in developing and adult human brain. Brain Res Bull. 2008; 69:546-559
4. Prevot V, Rio C, Cho GJ. Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J Neurosci. 2003;23:230-239
5. Wilson TR, Lee DY, Berry L, Shames DS, Settleman J. Neuregulin- 1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers. Cancer Cell. 2011;20:158-172
6. Zhao WJ, Ren SG. Endogenous neuregulin-1 expression in the anterior pituitary of female Wistar-Furth rats during the estrous cycle. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:921-927
7. Zhao W, Ren SG. Neuregulin-1 (Nrg1) is mainly expressed in rat pituitary gonadotroph cells and possibly regulates prolactin (PRL) secretion in a juxtacrine manner. J Neuroendocrinol. 2011; 23: 1252-1262
8. Zhao W, Shen Y, Ren S. Endogenous expression of neuregulin- 1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells. Cell Tissue Res. 2011;344:313-320
9. Hijazi MM, Thompson EW, Tang C et al. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines. Int J Oncol. 2000;17:629-641
10. Miller MW, Mooney SM, Middleton FA. Transforming growth factor beta1 and ethanol affect transcription and translation of genes and proteins for cell adhesion molecules in B104 neuroblastoma cells. J Neurochem. 2006; 97:1182-1190
11. Wu WK, Tse TT, Sung JJ, Li ZJ, Yu L, Cho CH. Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines. Anticancer Res. 2009; 29:229-234
12. Kopp R, Rothbauer E, Ruge M et al. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options. Recent Results Cancer Res. 2003;162:115-132
13. Zhang R, Li Q, Wang T, Guo YL. Interfering effect of neuregulin upon cerebral ischemic reperfusion injury in rhesus monkeys. Zhonghua Yi Xue Za Zhi.(chin). 2009;89:1361-1364
14. Li J, Qiang O, Wang L. Effects of neuregulin on cardiac myocyte apoptosis and PI-3K signal transduction pathway in rapid pacing-induced heart failure in rhesus monkeys. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32:408-412
15. Tang H, Huang H, Zhang Y, Chen J, Zhao Y, Wang L. Effects of recombined neuregulin on healthy Macaca mulatta hearts. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008;25:154-156
16. Thompson M, Lauderdale S, Webster MJ et al. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res. 2007; 1139:95-109
17. Sheng B, Gong K, Niu Y et al. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease. Free Radic Biol Med. 2009;46:1362-1375
18. Sheng B, Wang X, Su B et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem. 2012;120:419-429
19. Kataoka H, Joh T, Kasugai K et al. Expression of mRNA for heregulin and its receptor, ErbB3 and ErbB4, in human upper gastrointestinal mucosa.Life Sci. 1998;63:553-564
20. Tang CS, Ngan ES, Tang WK et al. Mutations in the NRG1 gene are associated with Hirschsprung disease. Hum Genet. 2012;131:67-76
21. Carraway KL, Carraway CA, Carraway KL 3rd. Roles of ErbB3 and ErbB4 in the physiology and pathology of the mammary gland. J Mammary Gland Biol Neoplasia. 1997;2:187-198
22. Alroy I, Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 1997;410:83-86
23. Karunagaran D, Tzahar E, Beerli RR et al. ErbB2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 1996;15:254-264
24. Tzahar E, Waterman H, Chen X et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol. 1996;16:5276-5287
25. Tvorogov D, Sundvall M, Kurppa K et al. Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer. J Biol Chem. 2009;284: 5582-5591
26. Yonezawa M, Wada K, Tatsuguchi A et al. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer. Digestion. 2009;80:215-225
27. Noguchi H, Sakamoto C, Wada K et al. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Gastroenterology. 1999;117: 1119-1127
28. Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L et al. The oncogenic ErbB2/ErbB3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene. 1998;16:1249-1258
29. Venkateswarlu S, Dawson DM, St Clair P, Gupta A, Willson JK, Brattain MG. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene. 2003;21:78-86
30. Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene. 2003;22:761-768
31. Frey MR, Hilliard VC, Mullane MT, Polk DB. ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells. Lab Invest. 2010;90:1415-1424
32. Whoriskey JS, Pekar SK, Elliott GS et al. A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitro. Growth Factors. 1998;15:307-321
33. Ebi M, Kataoka H, Shimura T et al. The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma. Mol Med Report. 2011;4:1151-1155
34. Motoyama AB, Hynes NE, Lane HA. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Cancer Res. 2002;62:3151-3158
35. Carón RW, Yacoub A, Zhu X et al. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Mol Cancer Ther. 2005; 4:243-255
36. Jackson JG, St Clair P, Sliwkowski MX, Brattain MG. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Cancer Res. 2004;64:2601-2609.